Skip to Content

Uluru Inc ULUR

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Uluru Inc is a US-based specialty medical technology company which focuses on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies, to improve outcomes for patients, healthcare professionals, and payers. The key product of the company Altrazeal Transforming Powder Dressing which is based on Nanoflex technology for wound treatment such as partial thickness burns, donor sites, abrasions, non-healing surgical wounds, trauma and chronic wounds including diabetic foot ulcers, venous leg ulcers, and pressure ulcers. The company also develops Nanoflex Powder platform which is a novel wound treatment technology used to promote the healing of exuding wounds.

4410 Beltway Drive
Addison, TX, 75001
T +1 214 905-5145
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2018
Fiscal Year End Dec 31, 2018
Stock Type Slow Growth
Employees 2